Urologic Oncology Fellowship
Program Description
The fellowship program in Urologic Oncology in UT Southwestern’s Department of Urology is designed for additional specialized training in both the clinical and research aspects of urologic oncology. The program is offered to U.S. residents completing their training who seek careers in academic urologic oncology.
The program is marked by a high volume of open and minimally invasive management of prostate, bladder, testes, renal, penile, and urethral malignancies. In addition, this fellowship features clinical and research experience with options in basic science, clinical trial design, and clinical outcomes research.
The program, which is currently approved as a Society of Urologic Oncology-accredited fellowship, offers a single two-year position each year. In the first year, the fellow immerses him/herself in research aspects of urologic oncology.
|
HOSPITAL STATISTICS |
UTSW |
PARKLAND |
DALLAS VA |
TOTAL |
|
Yearly |
958 |
256 |
226 |
1540 |
|
Major |
607 |
132 |
112 |
851 |
|
Minor |
351 |
124 |
114 |
589 |
|
Number of Urologic |
2594 |
672 |
452 |
3718 |
Research Program
The fellow may take a university graduate course in qualitative techniques such as biostatistics or research design in the Department of Clinical Sciences. Laboratories in the Department of Urology offer the fellow important opportunities to participate in research, which are centered on:
- Signal networking in prostate cancer
- Prostate stem cell
- Small molecule therapy
- Mechanisms of resistance in Androgen independent prostate cancer
- Bladder cancer gene therapy
- Epithelial mesenchymal transition in renal tumors
In addition, the many well-funded laboratories at the Harold C. Simmons Comprehensive Cancer Center are available as options for basic science research for the genitourinary (GU) oncology fellow.
The fellow also has access to a number of mature prospective databases that will allow him/her to investigate a number of GU oncology outcomes. Additionally, more than 20 active studies in the clinical research program are ongoing, including a number of investigator-initiated clinical trials in urologic oncology. These include a biomarker-based adjuvant chemotherapy trial in bladder cancer. The clinical research program also offers the GU oncology fellow the opportunity to become involved in clinical trials design.
Clinical Program
The clinical program is supervised by the Urologic Oncology faculty. Surgeries take place at UT Southwestern University Hospitals—Zale Lipshy and St. Paul, the Dallas Veterans Affairs Medical Center, and Parkland Memorial Hospital).
In all cases, the fellow will have direct supervision from an attending. In some instances, while under attending supervision, the fellow will have the opportunity to guide the resident in the outpatient setting.
The fellow will be expected to develop necessary skills to participate in collaborative and translational work. This will be facilitated through regular conferences at the Simmons Cancer Center, Parkland, andUT Southwestern.
In addition, our weekly multimodality meetings on Mondays, which are attended by Medical Oncology, Radiation Oncology, and Urologic Oncology, offer an interactive discussion of the management of each patient with urologic malignancies.
|
Month 1 |
Mon AM |
Surgery-minimally invasive treatment of GU malignancy with a focus on renal and prostate |
|
|
Mon PM |
Introduction to clinical trials with a focus on study design and it's application in the hospital setting (two hours) |
|
|
|
GU Mulitmodality Conference |
|
|
Tues AM |
Surgery - minimally invasive treatment of GU malignancy with a focus on renal and prostate malignancies (UTSW) |
|
|
Tues PM |
Outpatient clinical focus on urologic malignancies (Urology/Raj) |
|
|
|
Urology Surgical Planning Committee |
|
|
Wed AM |
Grand Rounds |
|
|
Wed |
Inpatient surgery at Parkland with emphasis on complex urologic malignancies |
|
|
Thurs AM |
Inpatient surgery with emphasis on bladder and testicular cancer treatments. Includes radical cystectomy with continent urinary diversions and complex retroperitoneal lymph node dissections (UTSW) |
|
|
Thurs PM |
Outpatient clinical focus on prostate cancer treatment options (Medical Oncology/Arriaga) |
|
|
Fri AM |
Cancer Center Combined Multimodality Conference |
|
|
Fri |
Inpatient surgery with focus on minimally invasive urologic malignancies (UTSW/Dallas VA) |